Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Klin Wochenschr ; 66 Suppl 12: 135-6, 1988.
Article in German | MEDLINE | ID: mdl-3126341

ABSTRACT

First experiences using rt-PA for the local lysis of peripheral arterial occlusions have shown that it is a potent activator of the fibrinolytic system. 2 to 5 mg of rt-PA administered for 1 to 1 1/2 hours are sufficient to completely dissolve even long occlusions. With doses up to 20 mg over 2 hours no systemic bleeding was observed. With 50 mg given within 5 hours and with an infusion of 2.5 mg per hour for 48 hours there were two cases of systemic haemorrhaging entirely due to the fibrinolysis. No appreciable defects in the coagulation system and no other side effects were observed.


Subject(s)
Arterial Occlusive Diseases/therapy , Recombinant Proteins/therapeutic use , Tissue Plasminogen Activator/therapeutic use , Aged , Graft Occlusion, Vascular/therapy , Humans , Ischemia/therapy , Leg/blood supply , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...